Healthgen Biotech

Wuhan Healthgen Biotechnology Corp. (referred to as "Healthgen Biotech") was established in 2006. It is a national high-tech enterprise specializing in the research of plant-based recombinant protein expression technology and product development. With a strong R&D team and complete, advanced protein purification process research facilities, the company has a series of independent core technologies and intellectual property protections. It has established a complete industrialization system and quality assurance system for China’s plant-derived biopharmaceuticals, and developed "one unique plant expression system and two technology platforms": the rice endosperm cell protein expression platform (OryzHiExp) and the protein purification platform (OryzPur). Healthgen Biotech has become an internationally renowned biopharmaceutical R&D center focusing on drug development and product innovation using plant systems. Healthgen Biotech has developed various recombinant protein raw material products that can be used in biopharmaceuticals/therapy and other fields. Among them, OsrHSA can be widely used in cell culture, drug carriers, vaccine stabilizers, cell cryopreservation protectants, and medical device embedding agents during biopharmaceutical production. Additionally, there are multiple cell growth factors and proteins for various cell cultures, such as FN, EGF, IGF-1, bFGF, VEGF, KGF, LF, LYZ, AAT, etc.